These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2412042)

  • 1. Antihypertensive properties of ketanserin in combination with beta-adrenergic blocking agents.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S161-3. PubMed ID: 2412042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.
    Hedner T; Persson B
    Br J Clin Pharmacol; 1984 Nov; 18(5):765-71. PubMed ID: 6150724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of arterial hypertension with ketanserin in mono- and combination therapy.
    Pettersson A; Persson B; Berglund G; Hedner T
    Clin Pharmacol Ther; 1985 Aug; 38(2):188-94. PubMed ID: 2861930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist.
    Weiner CP; Socol ML; Vaisrub N
    Am J Obstet Gynecol; 1984 Jul; 149(5):496-500. PubMed ID: 6377898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.
    Hedner T; Persson B; Berglund G
    Br J Clin Pharmacol; 1983 Aug; 16(2):121-5. PubMed ID: 6615685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single doses of ketanserin and placebo in chronic stable angina.
    Cameron HA; Cameron CM; Ramsay LE
    Br J Clin Pharmacol; 1986 Jul; 22(1):114-6. PubMed ID: 2874825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin in hypertension. Early clinical evaluation and dose finding study of a new 5-HT2 receptor antagonist.
    Andrén L; Svensson A; Dahlöf B; Eggertsen R; Hansson L
    Acta Med Scand; 1983; 214(2):125-30. PubMed ID: 6353879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a post-synaptic alpha-blocker.
    Rosenthal J; Koehle W; Gruebel B; Fisher R
    J Hypertens Suppl; 1986 Apr; 4(1):S85-7. PubMed ID: 2871145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
    Okin S; Huberfeld SI; Frishman WH; Soberman J; Laifer L; Greenberg S; Lapsker J; Charlap S; Strom JA
    J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
    Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
    J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative and long-term evaluation of ketanserin in the treatment of essential hypertension.
    Hedner T; Persson B; Berglund G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S148-53. PubMed ID: 2412038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antihypertensive effects of a pure and selective serotonin-receptor blocking agent (R 41 468) in elderly patients.
    De Cree J; Leempoels J; De Cock W; Geukens H; Verhaegen H
    Angiology; 1981 Feb; 32(2):137-44. PubMed ID: 7011110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with ketanserin and ritanserin in hypertensive patients.
    Hedner T; Persson B
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S44-8. PubMed ID: 2459514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of antihypertensive action of ketanserin in man.
    Reimann IW; Frölich JC
    Br Med J (Clin Res Ed); 1983 Aug; 287(6389):381-3. PubMed ID: 6135489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
    Cameron HA; Ramsay LE
    Postgrad Med J; 1985 Jul; 61(717):583-6. PubMed ID: 3161013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin combined with a beta-blocker or diuretic in essential hypertension. A multicentre study.
    Bartoloni C; Dupont P; Feltkamp H; Johnston CI; Steinbach K; Zilcher H; Kaindl F
    Eur J Clin Pharmacol; 1988; 35(6):573-7. PubMed ID: 2906874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
    Persson B; Gradin K; Pettersson A; Hedner T
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.